Browse Studies — Arctuva

Observational

A Post-market Multi-center Prospective Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Breast Cancer Stages I-III.

The purpose of this prospective study is to assess the ability of AMMA to prevent hair loss in women receiving chemotherapy (CT) for early-stage breast cancer.…

AlopeciaChemotherapy-induced AlopeciaHair Loss+1 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Cooler Heads Care Inc.NCT05484973

Phase 2

A Pilot Study of Low-Level Red-Light Therapy Combined With Topical Minoxidil Compared With Topical Minoxidil Alone in Breast Cancer Patients With Chemotherapy-Induced Alopecia

This phase II trial compares the safety and effectiveness of topical minoxidil alone to topical minoxidil in combination with low-level red-light therapy for i…

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Ohio State University Comprehensive Cancer CenterNCT07594678

Phase 2

Assessing the Impact of Scalp Cooling in With Metastatic Breast Cancer

This research is being done to compare rates of hair loss of people with metastatic breast who use scalp cooling versus those who do not use scalp cooling afte…

Metastatic Breast CancerChemotherapy-induced Alopecia

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT04986579